Expression of c-myc gene in human ovary carcinoma cells treated with vanadate
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 188 (1) , 169-171
- https://doi.org/10.1016/0014-4827(90)90294-k
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Vanadate can replace interleukin 3 for transient growth of factor-dependent cellsExperimental Cell Research, 1987
- THE myc ONCOGENE: ITS ROLE IN TRANSFORMATION AND DIFFERENTIATIONAnnual Review of Genetics, 1986
- Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteinsCell, 1985
- Structurally and functionally modified forms of pp60v-src in Rous sarcoma virus-transformed cell lysates.Molecular and Cellular Biology, 1984
- Identification, purification, and characterization of phosphotyrosine-specific protein phosphatases from cultured chicken embryo fibroblasts.Molecular and Cellular Biology, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadateBiochemical and Biophysical Research Communications, 1982
- Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.Proceedings of the National Academy of Sciences, 1977